hme

Karthik Ramasamy

United Kingdom
Karthik Ramasamy
Karthik Ramasamy

United Kingdom

Expert bio

Karthik Ramasamy is a Consultant Haematologist at Oxford University Hospitals NHS Trust and Associate Professor of Haematology, Radcliffe Department of Medicine, Oxford UK. Dr Ramasamy is the Director of the Oxford Myeloma Translational Research Centre, and a Lead Clinician for myeloma and other plasma cell dyscrasias at the Thames Valley Cancer Alliance Group. He is the Divisional Lead for Cancer research for National Institute for Health Research, Clinical Research Network Thames Valley and South Midlands, UK. He is an executive member of the UK Myeloma Forum and is an active member of UK Myeloma Research Alliance. Karthik has been appointed to Myeloma UK Board, a patient charity exclusively dealing with myeloma advocacy and research. Karthik is the Clinical Director of Haematology at Genesis Care UK, leading organisation in providing innovative and advanced cancer care in the UK. Dr Ramasamy completed his haematology training in London. Following this, he completed three years as a clinical research fellow working on bone marrow microenvironment in myeloma at King’s College London. Dr Ramasamy is a Chief Investigator of myeloma studies and his translational research interests are early diagnosis of myeloma, myeloma renal, bone disease and myeloma drug resistance mechanisms. Karthik has published over 50 papers and authored textbooks on myeloma.

EM-83229 - Date of preparation: November 2021

 

MORE INFORMATION
You can see my upcoming and previous webinars here.